Anika Therapeutics, Inc. (ANIK) Financials

ANIK Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 179.4 million 45.5 million
Dec. 31, 2025 190.3 million 46.8 million
Sept. 30, 2025 189.4 million 42.6 million
June 30, 2025 187.7 million 40.0 million

ANIK Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -6.3 million 6.6 million
Dec. 31, 2025 4.0 million 2.5 million
Sept. 30, 2025 5.0 million 2.2 million
June 30, 2025 -1.7 million 2.5 million

ANIK Net Income
Graph available only for paid members. Upgrade to see it.
DateNet Income
March 31, 2026 -5.1 million
Dec. 31, 2025 292000
Sept. 30, 2025 -2.3 million
June 30, 2025 -4.0 million

ANIK Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 41.0 million - 23.8 million
Dec. 31, 2025 57.5 million 24.2 million 26.2 million
Sept. 30, 2025 58.0 million - 22.8 million
June 30, 2025 53.2 million - 25.0 million

ANIK Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 13.5 million
Dec. 31, 2025 14.7 million
Sept. 30, 2025 14.4 million
June 30, 2025 14.4 million

ANIK Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 1.4 million 6.7 million 17.8 million -
Dec. 31, 2025 648000 6.5 million 12.1 million -
Sept. 30, 2025 1.9 million 6.9 million 11.9 million -
June 30, 2025 1.5 million 6.3 million 12.2 million -

ANIK Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 29.6 million 10.6 million
Dec. 31, 2025 30.6 million 11.4 million
Sept. 30, 2025 27.8 million 12.2 million
June 30, 2025 28.2 million 13.9 million

ANIK Revenue by Segment
Graph available only for paid members. Upgrade to see it.

ANIK

Price: $15.02

52 week price:
7.87
16.34

Earnings Per Share: -0.79 USD

Exchange: NMS

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Country: United States

Volume: 53407

Ebitda: 11.5 million

Market Capitalization: 204.4 million

Links: